BOLD MRI may serve as an indicator of blood oxygenation in the kidney and could potentially be used as a MRI biomarker in several kidney diseases. To be effective as a quantitative imaging biomarker, BOLD MRI must be an objective measure, independent of the MRI scanner model and MRI sequence implementation details. We have compared BOLD imaging across vendors in a tissue-mimicking phantom and in the healthy kidney by assessing R2* values in 12 concentric layers.
This abstract and the presentation materials are available to members only; a login is required.